Xu F - Search Results

1

Inducing Immunogenic Cancer Cell Death through Oxygen-Economized Photodynamic Therapy with Nitric Oxide-Releasing Photosensitizers.

Xu F, Wang M, Dotse E, Chow KT, Lo PC. Xu F, et al. Angew Chem Int Ed Engl. 2024 Sep 9;63(37):e202404561. doi: 10.1002/anie.202404561. Epub 2024 Aug 12. Angew Chem Int Ed Engl. 2024. PMID: 38887983

2

Cupric-ion-promoted fabrication of oxygen-replenishing nanotherapeutics for synergistic chemo and photodynamic therapy against tumor hypoxia.

He L, Xu F, Li Y, Jin H, Lo PC. He L, et al. Among authors: xu f. Acta Biomater. 2023 May;162:57-71. doi: 10.1016/j.actbio.2023.03.020. Epub 2023 Mar 20. Acta Biomater. 2023. PMID: 36944404

3

Near-infrared-activated anticancer platinum(IV) complexes directly photooxidize biomolecules in an oxygen-independent manner.

Deng Z, Li H, Chen S, Wang N, Liu G, Liu D, Ou W, Xu F, Wang X, Lei D, Lo PC, Li YY, Lu J, Yang M, He ML, Zhu G. Deng Z, et al. Among authors: xu f. Nat Chem. 2023 Jul;15(7):930-939. doi: 10.1038/s41557-023-01242-w. Epub 2023 Jun 22. Nat Chem. 2023. PMID: 37353602

4

Copper-coordinated nanoassemblies based on photosensitizer-chemo prodrugs and checkpoint inhibitors for enhanced apoptosis-cuproptosis and immunotherapy.

Liang W, Han C, Zhang D, Liu C, Zhu M, Xu F, Fang C, Zhang S, Liu C, Li Y. Liang W, et al. Among authors: xu f. Acta Biomater. 2024 Feb;175:341-352. doi: 10.1016/j.actbio.2023.12.022. Epub 2023 Dec 18. Acta Biomater. 2024. PMID: 38122883

5

Supramolecular catalytic nanomedicines based on coordination self-assembly of amino acids for cascade-activated and -amplified synergetic cancer therapy.

Song E, Wu Q, Gao R, Lan X, Zhang Y, Geng H, Liu C, Xu F, Li Y, Liu C. Song E, et al. Among authors: xu f. J Mater Chem B. 2022 Dec 7;10(47):9838-9847. doi: 10.1039/d2tb02326a. J Mater Chem B. 2022. PMID: 36448199

6

Dataset of tensile properties for sub-sized specimens of nuclear structural materials.

Li L, Merickel JW, Tang Y, Song R, Rittenhouse JE, Vakanski A, Xu F. Li L, et al. Among authors: xu f. Sci Data. 2025 Jan 11;12(1):48. doi: 10.1038/s41597-024-04329-2. Sci Data. 2025. PMID: 39799135

7

An engineered adeno-associated virus mediates efficient blood-brain barrier penetration with enhanced neurotropism and reduced hepatotropism.

Luo N, Lin K, Cai Y, Zhang Z, Sui X, Han Z, Yuan W, Xing J, Gui Z, Liu G, Wang J, Xu F. Luo N, et al. Among authors: xu f. J Control Release. 2025 Jan 9:S0168-3659(25)00024-0. doi: 10.1016/j.jconrel.2025.01.021. Online ahead of print. J Control Release. 2025. PMID: 39798705

8

Accelerative Effects of Transcutaneous Electrical Acustimulation on Postoperative Recovery After Thoracolumbar Vertebral Fracture Associated With Suppressed Sympathetic Activity and Interleukin-6.

Kang Y, Xu F, Wang Y, Gao X, Dong W, Lu L, Li F, Lin L, Chen JDZ. Kang Y, et al. Among authors: xu f. Neuromodulation. 2025 Jan 11:S1094-7159(24)01270-4. doi: 10.1016/j.neurom.2024.11.011. Online ahead of print. Neuromodulation. 2025. PMID: 39797896

9

WTAP-Mediated m6A Modification of TRAIL-DR4 Suppresses MH7A Cell Apoptosis.

Cui X, Xu F, Pang X, Fan C, Jiang H. Cui X, et al. Among authors: xu f. Int J Rheum Dis. 2025 Jan;28(1):e70065. doi: 10.1111/1756-185X.70065. Int J Rheum Dis. 2025. PMID: 39797510

10

Immunogenicity and safety of HepE Hecolin® in chronic hepatitis B patients at clinically stable stage: An open-label study in China.

Zhang L, Zhang Q, Liu J, Wu W, Jiang Z, Yan B, Cao Q, Liu H, Pan H, Lv J, Feng Y, Xu F, Huang S, Xu A. Zhang L, et al. Among authors: xu f. Hum Vaccin Immunother. 2025 Dec;21(1):2448882. doi: 10.1080/21645515.2024.2448882. Epub 2025 Jan 10. Hum Vaccin Immunother. 2025. PMID: 39797410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,210 results

Search Page

Filters